Suven Pharmaceuticals Limited
₹1,274.7
INR+12.40(+0.98%)
As of November 14, 2024 10:00:00 AMValuation Metrics
Market Cap
Total market value of the company's outstanding shares
₹32527.04 Cr
Enterprise Value
Total value of the company including debt and excluding cash
₹31802.73 Cr
P/E Ratio (TTM)
Price to Earnings ratio based on trailing 12 months
135.07
Forward P/E
Price to Earnings ratio based on forecasted earnings
NA
PEG Ratio
Price/Earnings to Growth ratio
NA
Price to Sales (TTM)
Price to Sales ratio based on trailing 12 months
34.81
Financial Metrics
Gross Margin
Gross profit as a percentage of revenue
60.69%
Operating Margin
Operating income as a percentage of revenue
28.84%
Return on Equity
Net income as a percentage of shareholders' equity
14.64%
Revenue (TTM)
Total revenue over trailing 12 months
₹934.49 Cr-33.6%
EBITDA
Earnings Before Interest, Taxes, Depreciation, and Amortization
₹340.87 Cr
EPS (TTM)
Earnings Per Share over trailing 12 months
₹9.46-49.6%
Balance Sheet
Total Cash
Total cash and short-term investments
₹821.13 Cr
Total Debt
Total short-term and long-term debt
₹65.00 Cr
Debt to Equity
Total debt as a percentage of shareholders' equity
3.17%
Stock Information
52 Week Range
Lowest and highest stock price over the past 52 weeks
₹542.1 - ₹1324.9
Beta
Measure of stock's volatility compared to the market
1.39
Shares Outstanding
Total number of shares issued by the company
₹25.46 Cr
Dividends & Splits
Forward Dividend Yield
Expected dividend yield based on forward dividend rate
1.53%
Trailing Dividend Yield
Dividend yield based on trailing 12 months
0.00%
Payout Ratio
Percentage of earnings paid as dividends
0.00%